Conferences

Last month the FDA approved pembrolizumab (KEYTRUDA) for adult and pediatric patients with with metastatic or unresectable, microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) solid tumors that have...

Inspirata will showcase its Cancer Diagnostic Cockpit and Consultation Portal as well as present scientific findings on a system that mines relevant information in cancer case reports. Pittsburgh, PA, May 22, 2017 – Cancer diagnostics and...

Hørsholm, Denmark, May 3rd - Visiopharm A/S announces the first result of their multifaceted strategy to apply Deep Learning technologies to its leading image analysis solution for cancer research and diagnostics. Visiopharm considers Deep...

Indica Labs proudly announces its breakthrough HALO® Deep Learning technology excelled in the CameLyon17 diagnostic image analysis competition.  The international challenge engaged commercial and academic teams worldwide to develop...

Proscia continues to demonstrate the potential for its technology demonstrating agreement between its algorithms and pathologist reads in detection and classification of breast cancer. Proscia Inc., a data and analytics solutions provider for...

 KEYNOTE PRESENTER ANNOUNCED Michael J. Becich, MD, PhD Chairman and Distinguished University Professor University of Pittsburgh School of Medicine The DPA is pleased to announce that Dr. Michael Becich will give the Keynote...